| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |